Neural Implants and Stimulation
Stimulation — not just recording — is delivering durable therapeutic benefit for movement disorders, epilepsy, depression, chronic pain, and paralysis. Closed-loop systems are the current frontier.
Key facts
- DBS is approved for at least 5 conditions globally, with 200,000+ implant recipients.
- Targeted epidural stimulation restored independent walking in tetraplegic patients (Lancet 2024).
- Closed-loop DBS (Medtronic Percept) is now clinically available.
- Over 1 million cochlear implant recipients globally.
- Focused ultrasound thalamotomy is FDA-approved for essential tremor.
Deep Brain Stimulation
DBS is FDA-approved for Parkinson's disease, essential tremor, dystonia, OCD (Humanitarian Device Exemption), and epilepsy (RNS, NeuroPace). Over 200,000 patients have received DBS implants globally.
Closed-loop systems (Medtronic Percept, NeuroPace RNS) now sense local field potentials and adjust stimulation in real time based on disease-state biomarkers.
Spinal Cord Stimulation
Conventional SCS is widely used for chronic pain. Targeted epidural stimulation (EPFL/CHUV STIMO trials, Onward) has restored walking in people with complete spinal cord injury — a result barely imaginable a decade ago.
Newer high-frequency and burst stimulation paradigms (Nevro Senza, Abbott BurstDR) show improved analgesia profiles.
Psychiatric Indications
DBS for treatment-resistant depression has been studied in multiple targets (subcallosal cingulate, ventral capsule/ventral striatum); recent personalized closed-loop work (Scangos et al., Nature Medicine 2021) showed dramatic single-patient results.
Focused ultrasound (Insightec) offers incisionless thermal ablation as an alternative for essential tremor and is in trials for OCD and depression.
Sensory Restoration
Cochlear implants are the most successful neural prosthesis ever deployed. Retinal implants have had a more difficult trajectory (Argus II discontinued, PRIMA / Pixium under development).
Auditory brainstem implants serve patients ineligible for cochlear implants; vestibular implants are in early trials for chronic dizziness.
Frequently asked
Is DBS dangerous?
+
Like any neurosurgery, it carries real risks (infection, hemorrhage, hardware failure) — but is well-tolerated overall and life-changing for many patients with otherwise refractory disease.
Can stimulation cure depression?
+
Not cure, but can produce durable response in treatment-resistant cases. Personalized closed-loop approaches show promise; large RCT evidence is still maturing.
How long do stimulators last?
+
Rechargeable IPGs commonly last 10–15 years; non-rechargeable batteries 3–7 years. Hardware revisions are routine over a patient's lifetime.
Sources & further reading
Continue in this series
Foundations
Brain-Computer Interfaces: An Overview
Industry
Neuralink, Synchron, and the BCI Industry
Frontier
Memory Prosthetics and Cognitive Augmentation
Ethics
Neurorights and the Ethics of Reading the Brain
Outlook
The Future of Brain-Computer Interfaces